Details for New Drug Application (NDA): 020309
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 020309 describes MAGNESIUM SULFATE IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Hq Spclt Pharma, Milla Pharms, and Mylan Labs Ltd, and is included in seven NDAs. It is available from eleven suppliers. Additional details are available on the MAGNESIUM SULFATE IN PLASTIC CONTAINER profile page.
The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
Summary for 020309
| Tradename: | MAGNESIUM SULFATE IN PLASTIC CONTAINER |
| Applicant: | Hospira |
| Ingredient: | magnesium sulfate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 020309
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309 | NDA | Hospira, Inc. | 0409-2050 | 0409-2050-20 | 20 POUCH in 1 CASE (0409-2050-20) / 1 BAG in 1 POUCH / 500 mL in 1 BAG (0409-2050-01) |
| MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309 | NDA | Hospira, Inc. | 0409-4121 | 0409-4121-50 | 50 POUCH in 1 CASE (0409-4121-50) / 1 BAG in 1 POUCH / 100 mL in 1 BAG (0409-4121-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 4GM/100ML (40MG/ML) | ||||
| Approval Date: | Jun 24, 1994 | TE: | AP | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 4GM/50ML (80MG/ML) | ||||
| Approval Date: | Jun 24, 1994 | TE: | AP | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/50ML (40MG/ML) | ||||
| Approval Date: | Jan 26, 2007 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
